Cargando…
The Geroprotective Drug Candidate CMS121 Alleviates Diabetes, Liver Inflammation, and Renal Damage in db/db Leptin Receptor Deficient Mice
db/db mice, which lack leptin receptors and exhibit hyperphagia, show disturbances in energy metabolism and are a model of obesity and type 2 diabetes. The geroneuroprotector drug candidate CMS121 has been shown to be effective in animal models of Alzheimer’s disease and aging through the modulation...
Autores principales: | Zahid, Saadia, Dafre, Alcir L., Currais, Antonio, Yu, Jingting, Schubert, David, Maher, Pamela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095029/ https://www.ncbi.nlm.nih.gov/pubmed/37047807 http://dx.doi.org/10.3390/ijms24076828 |
Ejemplares similares
-
Geroprotective effects of Alzheimer’s disease drug candidates
por: Kepchia, Devin, et al.
Publicado: (2021) -
CMS121, a fatty acid synthase inhibitor, protects against excess lipid peroxidation and inflammation and alleviates cognitive loss in a transgenic mouse model of Alzheimer's disease
por: Ates, Gamze, et al.
Publicado: (2020) -
Betaine Alleviates Hypertriglycemia and Tau Hyperphosphorylation in db/db Mice
por: Jung, Ga-young, et al.
Publicado: (2013) -
Linagliptin alleviates fatty liver disease in diabetic db/db mice
por: Michurina, Svetlana V, et al.
Publicado: (2016) -
Carvacrol may alleviate vascular inflammation in diabetic db/db mice
por: Zhao, Wei, et al.
Publicado: (2020)